Back

PRIME Education, Inc. (PRIME®)

  • Leukemia, Lymphocytic, Chronic, B-Cell

TP53 in CLL: Expert Strategies to Guide Treatment Decision-Making

Gain practical, expert-driven insights into the prognostic and predictive value of TP53 in CLL. This concise Clinical Pearls video explores why testing matters, how to integrate it into routine workflows, and how TP53 results can inform evidence-based treatment selection and improve patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Jan 30, 2026
  • Last day to claim credit
    Jan 30, 2027 4 months left